FDA Draft Guidance Paves Way For Collecting Clinical Study Data Via Digital Health Technologies

The US FDA released draft guidance on how device makers, investigators and other stakeholders can use digital health solutions to collect data from clinical study participants remotely. Comments are due to the agency by 22 March 2022.